🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Donna Przepiorka

United States Food and Drug Administration

ORCID: 0000-0002-4825-7775
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis”.

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0834
N/A
0DataRank · unranked
104 citations

Flora Mulkey, Emma Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab +9 more

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4271
N/A
0DataRank · unranked
82 citations

Kelly J. Norsworthy, Yaping Wang, Qing Xu, Hisham Qosa, Ramadevi Gudi +8 more

FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4176
N/A
0DataRank · unranked
56 citations

Robert Q. Le, Alexei Ionan, Ruo‐Jing Li, Yinghong Wang, Ramadevi Gudi +16 more

FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4525
N/A
0DataRank · unranked
25 citations

Xin Wang, Meng Li, Hongshan Li, Shwu‐Luan Lee, Nina Ni +9 more

FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0896
N/A
0DataRank · unranked
4 citations

Kamar Godder, Jingyan Wang, Justin S. Collazo, Robyn Konicki, Moran Choe +15 more

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1034
N/A
0DataRank · unranked
4 citations

Shu Wang, Ritu Chadda, Donna Przepiorka, Jonathon Vallejo, Xiling Jiang +3 more